In This Issue
- Centers for Early Detection and Interception Targets Individuals at Increased Risk
- Immunotherapy Trials in High-Risk Smoldering Multiple Myeloma
- Risk Stratifying CHIP and CCUS in Hematology Clinics
- Understanding the Role of the Microbiome in Immunotherapy Response in Myeloma
- Deciphering the Blood of Patients with Myeloma Precursor Conditions
- Faculty Spotlight: Virginia Volpe, MD
Additional Resources
Center for Early Detection and Interception of Blood Cancers
Jerome Lipper Multiple Myeloma Center
Adult Leukemia Program
Cellular Therapies Program
Centers for Early Detection and Interception